Anthrax infection
MONDO:0005119An infection caused by Bacillus anthracis bacteria. It may affect the lungs, gastrointestinal tract, or skin. Patients with lung infection present with fever, headaches, cough, chest pain and shortness of breath. Patients with gastrointestinal infection present with nausea, vomiting and bloody diarrhea. Patients with skin infection develop blisters and ulcers.
Also known as: Bacillus anthracis caused disease or disorder, Bacillus anthracis disease or disorder, Bacillus anthracis infectious disease, anthrax, anthrax disease
20 clinical trials for this condition and its sub-types, 17 tagged with Anthrax infection itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Anthrax infection
-
Inhalational anthrax 4 trials
-
Injection anthrax 3 trials
-
Cutaneous anthrax 2 trials
-
Gastrointestinal anthrax 2 trials
1 sub-type
- Oropharyngeal anthrax 0 trials
-
New anthrax vaccine moves forward in human trials
Vaccine OngoingThis study tests an anthrax vaccine called AV7909 in 220 healthy adults aged 18 to 65. The goal is to see how safe it is and how well it triggers the immune system, using two different dosing schedules and booster shots at 6 and 12 months. Participants will be monitored for side …
Phase 2 • Sponsor: Biomedical Advanced Research and Development Authority • Aim: Vaccine
Last updated Jun 27, 2026 09:07 UTC
-
Charcoal may skew lab results, study warns
Knowledge-focused OngoingThis study looks at whether taking activated charcoal can change certain blood test results, like osmolality and ethylene glycol levels. Eight healthy volunteers will take a dose of charcoal and have blood drawn over six hours. The goal is to see if charcoal causes false positive…
Sponsor: State University of New York - Upstate Medical University • Aim: Knowledge-focused
Last updated Aug 02, 2026 00:00 UTC
-
Charcoal experiment to reverse blood thinners halted before it began
Knowledge-focused CancelledThis study was designed to see if taking activated charcoal could help clear certain blood thinners (rivaroxaban, apixaban) faster in patients needing an urgent procedure. It planned to enroll 140 adults and measure how quickly the drug left their blood. However, the trial was wi…
Phase 4 • Sponsor: University Hospital, Angers • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC